Gene · 7172
Papers3,004
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,004
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unveiling the heritability of selected unexplored pharmacogenetic markers in the Saudi population. | Front Pharmacol | 2025 | 40376268 | PubTator, text mining | PubMed |
| Treatment burden in glomerular diseases: advances and challenges in immunosuppressive therapy. | Front Nephrol | 2025 | 40376095 | PubTator, text mining | PubMed |
| Leveraging long-read sequencing technologies for pharmacogenomic testing: applications, analytical strategies, challenges, and future perspectives. | Front Genet | 2025 | 40370700 | PubTator, text mining | PubMed |
| Evaluation of the interactions of hydrazide derivatives with acetic acid and molecular modeling analysis of N-acetylated hydrazides. | RSC Adv | 2025 | 40296993 | PubTator, text mining | PubMed |
| Estimating the Frequency of False-Negative Pharmacogenetic Test Results by Self-Reported Ancestry. | Clin Pharmacol Ther | 2025 | 40287944 | PubTator, text mining | PubMed |
| Usefulness of thiopurines therapeutic drug monitoring in patients with inflammatory bowel disease. | Therapie | 2025 | 40240270 | PubTator, text mining | PubMed |
| Pharmacogenomics in pediatric oncology patients with solid tumors related to chemotherapy-induced toxicity: A systematic review. | Crit Rev Oncol Hematol | 2025 | 40222694 | PubTator, text mining | PubMed |
| Pharmacogenetics to optimize immunosuppressant therapy in systemic lupus erythematosus: a scoping review. | Pharmacogenomics | 2025 | 40208755 | PubTator, text mining | PubMed |
| Proactive pharmacogenomics in azathioprine-treated pediatric inflammatory bowel disease at a Chinese tertiary hospital. | Front Pharmacol | 2025 | 40206080 | PubTator, text mining | PubMed |
| Perspectives in clinical research on Azathioprine for steroid-dependent ulcerative colitis. | Front Med (Lausanne) | 2025 | 40201324 | PubTator, text mining | PubMed |
| The Missing Enzymes: A Call to Update Pharmacological Profiling Practices for Better Drug Safety Assessment. | J Med Chem | 2025 | 40173276 | PubTator, text mining | PubMed |
| Opportunities and Challenges of Population Pharmacogenomics. | Ann Hum Genet | 2025 | 40171627 | PubTator, text mining | PubMed |
| Therapeutic Drug Monitoring of Thiopurines in Patients With Inflammatory Bowel Disease: Observations From Daily Practice. | Ther Drug Monit | 2025 | 40152645 | PubTator, text mining | PubMed |
| Pharmacogenomics in Solid Tumors: A Comprehensive Review of Genetic Variability and Its Clinical Implications. | Cancers (Basel) | 2025 | 40149251 | PubTator, text mining | PubMed |
| Pharmacogenomic variants in the Pumi population from Yunnan, China. | Gene | 2025 | 40113188 | PubTator, text mining | PubMed |
| Pharmacogenomics of Chemotherapies for Childhood Cancers in Africa: A Scoping Review. | Pharmgenomics Pers Med | 2025 | 39968370 | PubTator, text mining | PubMed |
| Impact of Pharmacogenomic Testing in Pediatric Heart and Kidney Transplant. | Pediatr Transplant | 2025 | 39924350 | PubTator, text mining | PubMed |
| Thiopurine S-methyltransferase - An important intersection of drug-drug interactions in thiopurine treatment. | Biomed Pharmacother | 2025 | 39923408 | PubTator, text mining | PubMed |
| Effectiveness and safety of thiopurines in inflammatory bowel disease patients with NUDT15 polymorphism: a real-world retrospective study. | Expert Rev Clin Pharmacol | 2025 | 39921705 | PubTator, text mining | PubMed |
| Clinical relevance of thiopurine methyltransferase genotype testing for azathioprine in dermatology. | Clin Exp Dermatol | 2025 | 39920408 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7172/papers?page=7